Kenneth Levesque
Psychiatric/Mental Health · Hickory, NCNPI 1730768896
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (48.6%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Noven Pharmaceuticals, Inc. at 49.9% of the total. Reporting peaked in 2022 at $2,713 and has fallen 86.5% since, to $367 in 2025. Among psychiatric/mental health clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 250 payments — averaging $39.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Noven Pharmaceuticals, Inc.$5K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$747
- Sunovion Pharmaceuticals Inc.$709
- AbbVie$595
- Alkermes, Inc.$534
- Teva Pharmaceuticals USA, Inc.$503
- plus $2K from 14 others
What the payments were for
- Consulting fees$410%
- Speaking & faculty fees$3,22832%
- Travel & lodging$1,61616%
- Food & beverage$4,85549%
- Education$2523%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Noven Pharmaceuticals, Inc. | 9 | $4,982 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 27 | $747 |
| Sunovion Pharmaceuticals Inc. | 44 | $709 |
| AbbVie | 30 | $595 |
| Alkermes, Inc. | 19 | $534 |
| Teva Pharmaceuticals USA, Inc. | 21 | $503 |
| Johnson & Johnson | 13 | $404 |
| Otsuka America Pharmaceutical, Inc. | 14 | $356 |
| Neurocrine Biosciences, Inc. | 17 | $304 |
| Almatica Pharma LLC | 18 | $210 |
| Vanda Pharmaceuticals Inc. | 10 | $177 |
| Noven Therapeutics, LLC | 11 | $173 |
| Indivior Inc. | 5 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $67 |
| E.r. Squibb & Sons, L.L.C. | 1 | $62 |
| Lundbeck LLC | 2 | $29 |
| Supernus Pharmaceuticals, Inc. | 1 | $23 |
| Eisai Inc. | 1 | $20 |
| Bausch Health US, LLC | 1 | $13 |
| Corium, LLC | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Xelstrym$4,969
- LYBALVI$500
- ARISTADA$405
- CAPLYTA$353
- VRAYLAR$273
- INVEGA SUSTENNA$264
- REXULTI$125
- ARISTADA INITIO$101
How this compares
$9,992 in reported general payments places this provider in the 95th percentile of 947 psychiatric/mental health providers in North Carolina.
See all psychiatric/mental health providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 30 | $20,583 |
| Loreev XrLorazepam | 22 | $5,674 |
| Divalproex Sodium | 23 | $1,164 |
| Buspirone Hcl | 90 | $1,052 |
| Duloxetine Hcl | 20 | $472 |
| Escitalopram Oxalate | 35 | $314 |
| Trazodone Hcl | 19 | $252 |
| Lorazepam | 35 | $243 |
| Fluoxetine Hcl | 19 | $212 |
| Quetiapine Fumarate | 22 | $211 |
| Sertraline Hcl | 20 | $144 |
| Risperidone | 11 | $71 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti | $356 | $20,58330 claims |
| Almatica Pharma LLCLoreev Xr, Sertraline Hcl | $210 | $5,81942 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 947 psychiatric/mental health providers in North Carolina.
Other psychiatric/mental health in Hickory
- Francis PenlandHickory$17K
- Alicia BuckHickory$9K
- Sharon Golden MyersHickory$8K
- Desiree MatthewsCharlotte$807K
- Benedetto PalomboCharlotte$671K
- Clarence RunnelsCreedmoor$339K
- Lisa SuddrethGastonia$111K
- April NandigamGreensboro$88K
- Hannah NealeyFuquay Varina$75K
- Jessica StoneRocky Mount$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.